Mechanisms of Fate Evolution of Colorectal Adenocarcinoma Metastasis
NCT04714814 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2021-03-23
Summary
This is a two stage nested case-control study to construct the hologram plane , explore biomarkers and screening original drugs of metastatic colorectal cancer.
Conditions
- Colorectal Cancer Stage III
- Colorectal Cancer Stage IV
Sponsors & Collaborators
-
Shanghai Municipal Science and Technology Commission
collaborator OTHER_GOV -
RenJi Hospital
collaborator OTHER -
Shanghai Jiao Tong University School of Medicine
collaborator OTHER -
Shanghai Minimally Invasive Surgery Center
lead OTHER
Principal Investigators
-
Sun Jing, PhD · Shanghai Jiao Tong University School of Medicine
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-06-01
- Primary Completion
- 2022-05-01
- Completion
- 2023-05-01
Countries
- China
Study Locations
More Related Trials
-
The Culture of Advanced/Recurrent/Metastatic Colorectal Cancer Organoids and Drug Screening
NCT05304741 ·Status: UNKNOWN
-
Strengthening the Spleen and Reducing Phlegm Method in Improving Radical Resection Rate of Colorectal Cancer
NCT03716063 ·Status: UNKNOWN ·Phase: PHASE3
-
The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey
NCT01549067 ·Status: UNKNOWN
-
Tumor Response Prediction in Neoadjuvant Chemoradiation of Locally Advanced Rectal Cancer Using Metabonomics Analysis
NCT03149978 ·Status: UNKNOWN
-
Application of Radiomics in Precise Preoperative Diagnosis and Prognsis Evaluation of Colorectal Cancer.
NCT03787667 ·Status: UNKNOWN
-
Comprehensive Analysis of Gut Microbiota Signatures in Metastatic Colorectal Cancer
NCT07154173 ·Status: RECRUITING
-
Efficacy of Combination Immunotherapy in Patients With Metastatic Colorectal Cancer
NCT05414461 ·Status: COMPLETED ·Phase: PHASE2
-
Early Blocking Strategy for Metachronous Liver Metastasis of Colorectal Cancer Based on Pre-hepatic CTC Detection
NCT05720559 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Prospective, Multi-center, Real-world Study of Ovarian Metastatic Colorectal Cancer Patients
NCT04716257 ·Status: RECRUITING
-
Metabolism Imaging-genomics for Predicting the Surgical Outcomes of Colorectal Cancer
NCT06614660 ·Status: ACTIVE_NOT_RECRUITING
-
Epidermal Growth Factor Receptor (EGFR) Antagonist Chimeric Anti-EGFR Monoclonal Antibody Trial
NCT03426371 ·Status: TERMINATED ·Phase: PHASE3
-
Postoperative Chemotherapy With/Without Radiotherapy and Immunotherapy for Colorectal Liver Metastases With High Risk of Locally Recurrence
NCT06120127 ·Status: RECRUITING ·Phase: PHASE2
-
A Study on Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC)
NCT06749015 ·Status: RECRUITING
-
Constructing a Multimodal Imaging System to Predict the Risk of Heterochronous Metastasis of Rectal Cancer
NCT06293612 ·Status: COMPLETED
-
Patient-derived Organoids Predicts the Clinical Efficiency of Colorectal Liver Metastasis
NCT05183425 ·Status: UNKNOWN
-
Prognosis Stratification for pT4bN0M0 Colorectal Cancer Following Multivisceral Resection
NCT06115837 ·Status: COMPLETED
-
Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA
NCT05797077 ·Status: RECRUITING ·Phase: PHASE3
-
Molecular Study and Precision Medicine for Colorectal Cancer
NCT05883683 ·Status: NOT_YET_RECRUITING
-
A Real-world Study of Chidamide in Combination with PD-1/PD-L1 Antibodies and Anti-angiogenic Agents in Advanced MSS Colorectal Cancer
NCT06682247 ·Status: NOT_YET_RECRUITING
-
Neoadjuvant Triplet Chemotherapy Regimen in Patients With Resectable Colorectal Cancer
NCT02688023 ·Status: UNKNOWN ·Phase: PHASE2
-
Maintenance Treatment With Capecitabine in Colorectal Cancer Patients
NCT02027363 ·Status: UNKNOWN ·Phase: PHASE2
-
A Phase Ⅱ Study of XELOX Chemotherapy With or Without Surgery of Primary Lesion for Colon Cancer Patients
NCT02291744 ·Status: UNKNOWN ·Phase: PHASE2
-
The Value of Palliative Primary Tumor Resection in Metastatic Colon Cancer
NCT04416854 ·Status: RECRUITING ·Phase: PHASE3
-
The Clinical Outcome and the Exploration of Related Biomarkers of Target Therapy in Metastasis Colorectal Cancer
NCT02523495 ·Status: UNKNOWN
-
Surgery Following Immune Checkpoint Inhibitions for Controlled Disease in Recurrent or Metastatic dMMR/MSI-H Colorectal Cancer
NCT06717763 ·Status: COMPLETED